REFERENCES
- Robertson WG, Peacock M. The cause of idiopathic calcium stone disease: hypercalciuria or hyperoxaluria? Nephron 1980; 26: 105–10.
- Ryall RL, Marshall VR. The investigation and manage-ment of idiopathic urolithiasis. In: Buck AC, Wickham JEA, eds. Renal tract stone. Metabolic basis and clinical practice. Edinburgh: Churchill Livingstone, 1990: 307–31.
- Kasidas GP, Rose GA. Removal of ascorbate from urine prior to assaying with a commercial oxalate kit. Clin Chim Acta 1987; 164: 215–21.
- Tiselius H-G. Metabolic evaluation of patients with stone disease. Urol Int 1997; 59: 131–41.
- Laerum E, Palmer H. Methodological aspects of exam-ination of 24hr urinary excretions in outpatients with recurrent urolithiasis. Scand J Urol Nephrol 1983; 17: 321–4.
- Zarembski PM, Hodgkinson A. Some factors influencing the urinary excretion of oxalic acid in man. Clinica Chimica Acta 1969; 25: 1–10.
- Khan SR. Calcium oxalate crystal interaction with renal tubular epithelium, mechanism of crystal adhesion and its impact on stone development. Urol Res 1995; 23: 71–9.